enGene Therapeutics ENGN Ratios (2022-2026)

NASDAQ ENGN
$1.79 +0.02 (+1.13%)
As of: Aug 21, 2026 · 11:57 AM EDT
Ratios Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Efficiency
Assets Average (Quarter) 90.19M183.47M270.20M289.03M298.55M276.29M256.10M233.51M279.29M322.32M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -3.94-4.02-4.330.01M-17.96-0.42-0.81-110.47-33.27-6.06-7.25-27.88-42.60-2.94
Debt Ratio (Quarter) 0.400.110.240.080.080.070.080.080.070.070.070.08
Times Interest Earned (Quarter) -3.94-4.02-4.330.01M-17.96-0.42-0.81-110.47-33.27-6.06-7.25-27.88-42.60-2.94
Valuation
Enterprise Value (Quarter) -20.43M-81.52M-85.65M-264.81M-257.68M-238.33M-213.81M-217.39M-201.91M-193.74M-275.95M-258.46M
Return Ratios
Return on Capital Employed (Quarter) -38.66%-25.27%-21.53%-22.71%-27.36%-34.05%-42.92%-61.11%-50.16%-44.07%
Return on Assets (Quarter) -0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%